Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies

BACKGROUND: Inhaled corticosteroids (ICS) are widely used and recommended to treat chronic obstructive pulmonary disease (COPD). While generally considered safe, several studies demonstrated an increased risk of pneumonia with the use of ICS in COPD patients. Although all ICS indicated for COPD carr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodise, Thomas P, Li, Jingyi, Gandhi, Hitesh N, O’Brien, Gerald, Sethi, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667513/
https://www.ncbi.nlm.nih.gov/pubmed/33204085
http://dx.doi.org/10.2147/COPD.S269637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667513/
https://www.ncbi.nlm.nih.gov/pubmed/33204085
http://dx.doi.org/10.2147/COPD.S269637

Ejemplares similares